CClinicalTrials.gg
CompletedNCT04609371Updated Sep 21, 2021

PanDirect: Self-care Tools and Telephone Coaching for Depression and Anxiety During Pandemics

An interventional study of self-care tools and lay telephone coaching in Mental Health Wellness 1, Coaching and Pandemic, sponsored by St. Mary's Research Center, Canada. Completed at 1 site in Canada. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2021-09-21.

Sponsored by St. Mary's Research Center, Canada · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

During pandemics older adults with chronic physical conditions are a particularly vulnerable population for unmet mental health needs. This is a consequence of a number of factors which include decreased access to their doctors because of restrictions in visits in order to decrease risk of disease transmission and because doctors are seconded to provide medical services in areas of high priority. Since Public Health authorities worry that pandemics may be a reality of the future, this study is being operationalized during the present COVID-19 pandemic in order to see what can be learned about different ways to provide mental health care under such constraints.

The study offers evidence-based approaches to managing feelings of anxiety or depression that may have existed prior to the onset of a pandemic, or that have arisen during a pandemic. It uses principles of cognitive behavioural therapy in which participants are offered self-care tools to help them develop strategies for dealing with their various symptoms. These tools have already been shown by the team to be effective in other contexts in studies DIRECT-sc (Effectiveness of a supported self-care intervention for depression compared to an unsupported intervention in older adults with chronic physical illnesses) and CanDIRECT (Effectiveness of a telephone-supported depression self-care intervention for cancer survivors).

The present study, PanDIRECT (Assisting Family Physicians with Gaps in Mental Health Care Generated by the COVID-19 Pandemic), aims to answer the following questions:

  1. Can these tools be used in the community care of mental health problems during pandemics?
  2. Are they acceptable to patients?
  3. Using a randomized control trial, does lay-coaching of use of these tools improve their use and patient outcomes?
  4. Do family practitioners value patient information sent to them at the end of the trial
02

Conditions studied

  • Mental Health Wellness 1
  • Coaching
  • Pandemic
  • Depression, Anxiety
  • Self-care Tools
03

In context

Depression

8,057 studies on the registry are indexed under Depression; 1,641 are open to participants now.

This study's enrollment of 90 is close to the median of 84 across 6,720 interventional studies indexed under Depression.

Browse Depression studies →

Lead sponsor

St. Mary's Research Center, Canada is the lead sponsor of 11 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • 65+ years old
  • consented to be recontacted (participant in a previous study)

Exclusion criteria

Exclusion criteria:

  • moderate to severe cognitive impairment (using BOMC a brief cognitive screen) -unable to read in English or French (self-reported); hearing impairment (as judged by research staff);
  • currently receiving counseling or psychological therapy (as these treatments may conflict with the self-care interventions)
  • currently living in a long term care or other medicalized facility,
  • presenting suicidal intent (as identified through the final item of the PHQ-9 which will be asked at screening).
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
90 participants (actual)

Study arms

  • Experimental
    self-care tools

    Arms Assigned Interventions Experimental: self-care tools The tools are adapted from those successfully deployed in the DIRECTsc depression self-care project focusing on patients with depressive symptoms, but abbreviated to meet the needs of the proposed short-term intervention for a broader sample of patients to include those with anxiety symptoms and with minimal symptoms. Tools will include individual chapters of the Antidepressant Skills Workbook; the mood monitoring tool; a workbook on managing worry; relaxation audio files and information on exercise and healthy eating. In view of the short duration of the intervention (8 weeks), a maximum of 2 tools will be sent to each participant. An algorithm will determine which self-care tools, matched to the specific mental health symptoms reported by participants, will be sent to the participants.

    Behavioral: self-care tools

  • Experimental
    coaching

    Participants will receive the algorithm-determined self-care tools, matched to the specific mental health symptoms reported by participants as in the first arm. They will ALSO be offered up to 3 coach calls. Coaching by a trained lay coach will be structured and guided by a manual. Trained lay coaches will call participants in the week following delivery of the toolkit to guide them through the self-care toolkit over an 8-week period. Coaches will contact participants a maximum of 3 times, with calls expected to average 15-20 minutes. Call content will be guided by a structured coaching manual adapted from those used in the team's previous two RCTs of the self-care materials. The coaches will follow structured agendas, keep records of all contacts.

    Behavioral: self-care tools · Behavioral: lay telephone coaching

Interventions

  • Behavioralself-care tools

    self-care tools only

  • Behaviorallay telephone coaching

    coaching

06

What researchers measure

Primary outcomes

  1. Consent rate

    Number of consenting participants out of total number contacted over the recruitment period

    Time frame: At recruitment

  2. Data completion rate

    Investigators will report on rates of missing data from baseline and follow-up questionnaires

    Time frame: From recruitment launch to completion of follow-up (4 months)

  3. Fidelity of intervention completion

    Logs and checklists will be used to evaluate completion of intervention, as per protocol

    Time frame: A 8 week follow-up

  4. Severity of depression symptoms

    Using the validated 9 item Patient Health Questionnaire (PHQ-9). Scores range from 0 to 27 - higher score indicates more severe depression

    Time frame: At baseline

  5. Severity of depression symptoms

    Using the validated 9 item Patient Health Questionnaire (PHQ-9). Scores range from 0 to 27 - higher score indicates more severe depression

    Time frame: At 8 week follow-up

  6. Severity of anxiety symptoms

    Using the validated 7 item General Anxiety Disorder (GAD-7) instrument. Scores range from 0 to 21 - higher score indicates more severe anxiety

    Time frame: At baseline

  7. Severity of anxiety symptoms

    Using the validated 7 item General Anxiety Disorder (GAD-7) instrument. Scores range from 0 to 21 - higher score indicates more severe anxiety

    Time frame: At 8 week follow-up

  8. Use of health care services

    Using questions developed by the team and administrative databases to assess use of hospital and mental health care services

    Time frame: At baseline

  9. Use of health care services

    Using questions developed by the team and administrative databases to assess use of hospital and mental health care services

    Time frame: At 8 week follow-up

  10. Use of the self-care materials

    Using adherence questions developed by the team, not scored

    Time frame: At 8 week follow-up

07

Study locations

1 site
  • St Mary's Hospital Research Centre
    Montréal, Canada
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 21, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04609371
Lead sponsor
St. Mary's Research Center, Canada
Responsible party
Mark Yaffe (Professor, Department of Family Medicine, McGill University and Family physician, St. Mary's Hospital Center, St. Mary's Research Center, Canada) — Principal investigator
First posted
Oct 30, 2020
Start date
Oct 21, 2020
Primary completion
Mar 1, 2021
Completion
May 1, 2021
Last update
Sep 21, 2021

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion